Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098616191> ?p ?o ?g. }
- W2098616191 endingPage "1478" @default.
- W2098616191 startingPage "1469" @default.
- W2098616191 abstract "Abstract. A potential role of the sympathetic nervous system in progression of renal failure has received little attention. This study examined whether nonhypotensive doses of moxonidine, an agent that reduces sympathetic activity, affects glomerulosclerosis, urine albumin excretion, and indices of renal handling of norepinephrine (NE) in subtotally nephrectomized (SNX) rats. Sprague Dawley rats were SNX or sham-operated (control). SNX rats were either left untreated or treated with moxonidine in a dose (1.5 mg/kg body wt per d) that did not modify telemetrically monitored 24-h BP. Glomerular and renal morphology were evaluated by quantitative histology, immunohistochemistry, and in situ hybridization. Urine albumin excretion rate was analyzed by enzyme-linked immunosorbent assay, and kidney angiotensin II and NE content were measured using HPLC, 3 H-NE uptake, and release. Body and kidney weight and BP were not significantly different between SNX with or without moxonidine. The glomerulosclerosis index was significantly lower in moxonidine-treated (0.88 ± 0.09) compared with untreated (1.55 ± 0.28) SNX rats, as was the index of vascular damage (0.32 ± 0.14 versus 0.67 ± 0.16). The number of proliferating cell nuclear antigen-positive glomerular and tubular cells per area was significantly higher in untreated SNX rats than in controls and moxonidine-treated SNX rats. The same was true for urine albumin excretion rate. Renal angiotensin II tissue concentration was not affected by moxonidine. In untreated SNX rats, renal nerve stimulation and exogenous NE induced an increase in isolated kidney perfusion pressure (102 ± 21 versus 63 ± 8 mmHg). Renal endogenous NE content was significantly lower in SNX rats than in controls (86 ± 14 versus 140 ± 17 pg/mg wet weight). Cortical uptake of [ 3 H]-NE was not different, but cortical NE release was significantly higher in SNX rats than in controls. Reduced function of presynaptic inhibitory α-adreno-receptors is unlikely because an α 2 -adrenoceptor antagonist increased NE release. At subantihypertensive doses, moxonidine ameliorates renal structural and functional damage in SNX animals, possibly through central inhibition of efferent sympathetic nerve traffic. In kidneys of SNX rats, indirect evidence was found for increased activity of a reduced number of nerve fibers." @default.
- W2098616191 created "2016-06-24" @default.
- W2098616191 creator A5004432141 @default.
- W2098616191 creator A5014930425 @default.
- W2098616191 creator A5016805682 @default.
- W2098616191 creator A5022731076 @default.
- W2098616191 creator A5025054029 @default.
- W2098616191 creator A5043895832 @default.
- W2098616191 creator A5046297316 @default.
- W2098616191 creator A5049496369 @default.
- W2098616191 creator A5051985691 @default.
- W2098616191 creator A5068721240 @default.
- W2098616191 creator A5075578189 @default.
- W2098616191 creator A5083173107 @default.
- W2098616191 creator A5087116722 @default.
- W2098616191 date "2000-08-01" @default.
- W2098616191 modified "2023-10-18" @default.
- W2098616191 title "Effects of Low Dose Sympathetic Inhibition on Glomerulosclerosis and Albuminuria in Subtotally Nephrectomized Rats" @default.
- W2098616191 cites W1961262965 @default.
- W2098616191 cites W1967662494 @default.
- W2098616191 cites W1970371480 @default.
- W2098616191 cites W1971498397 @default.
- W2098616191 cites W1973039709 @default.
- W2098616191 cites W1973485709 @default.
- W2098616191 cites W1973871661 @default.
- W2098616191 cites W1993599355 @default.
- W2098616191 cites W1995381509 @default.
- W2098616191 cites W2011732527 @default.
- W2098616191 cites W2014420640 @default.
- W2098616191 cites W2018243449 @default.
- W2098616191 cites W2024549556 @default.
- W2098616191 cites W2038872854 @default.
- W2098616191 cites W2041592234 @default.
- W2098616191 cites W2049453613 @default.
- W2098616191 cites W2054163031 @default.
- W2098616191 cites W2055139975 @default.
- W2098616191 cites W2066656845 @default.
- W2098616191 cites W2068444233 @default.
- W2098616191 cites W2095173028 @default.
- W2098616191 cites W2109052012 @default.
- W2098616191 cites W2124579523 @default.
- W2098616191 cites W2135213898 @default.
- W2098616191 cites W2139284913 @default.
- W2098616191 cites W2148083193 @default.
- W2098616191 cites W2161791944 @default.
- W2098616191 cites W2162232882 @default.
- W2098616191 cites W2171278811 @default.
- W2098616191 cites W2196751099 @default.
- W2098616191 cites W2318993770 @default.
- W2098616191 cites W2323009138 @default.
- W2098616191 cites W4231748040 @default.
- W2098616191 cites W4242885359 @default.
- W2098616191 cites W4245863869 @default.
- W2098616191 doi "https://doi.org/10.1681/asn.v1181469" @default.
- W2098616191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10906160" @default.
- W2098616191 hasPublicationYear "2000" @default.
- W2098616191 type Work @default.
- W2098616191 sameAs 2098616191 @default.
- W2098616191 citedByCount "167" @default.
- W2098616191 countsByYear W20986161912012 @default.
- W2098616191 countsByYear W20986161912013 @default.
- W2098616191 countsByYear W20986161912014 @default.
- W2098616191 countsByYear W20986161912015 @default.
- W2098616191 countsByYear W20986161912016 @default.
- W2098616191 countsByYear W20986161912017 @default.
- W2098616191 countsByYear W20986161912018 @default.
- W2098616191 countsByYear W20986161912019 @default.
- W2098616191 countsByYear W20986161912020 @default.
- W2098616191 countsByYear W20986161912021 @default.
- W2098616191 countsByYear W20986161912022 @default.
- W2098616191 crossrefType "journal-article" @default.
- W2098616191 hasAuthorship W2098616191A5004432141 @default.
- W2098616191 hasAuthorship W2098616191A5014930425 @default.
- W2098616191 hasAuthorship W2098616191A5016805682 @default.
- W2098616191 hasAuthorship W2098616191A5022731076 @default.
- W2098616191 hasAuthorship W2098616191A5025054029 @default.
- W2098616191 hasAuthorship W2098616191A5043895832 @default.
- W2098616191 hasAuthorship W2098616191A5046297316 @default.
- W2098616191 hasAuthorship W2098616191A5049496369 @default.
- W2098616191 hasAuthorship W2098616191A5051985691 @default.
- W2098616191 hasAuthorship W2098616191A5068721240 @default.
- W2098616191 hasAuthorship W2098616191A5075578189 @default.
- W2098616191 hasAuthorship W2098616191A5083173107 @default.
- W2098616191 hasAuthorship W2098616191A5087116722 @default.
- W2098616191 hasBestOaLocation W20986161911 @default.
- W2098616191 hasConcept C10146269 @default.
- W2098616191 hasConcept C126322002 @default.
- W2098616191 hasConcept C134018914 @default.
- W2098616191 hasConcept C170493617 @default.
- W2098616191 hasConcept C185592680 @default.
- W2098616191 hasConcept C2776174234 @default.
- W2098616191 hasConcept C2777014715 @default.
- W2098616191 hasConcept C2777390665 @default.
- W2098616191 hasConcept C2778938600 @default.
- W2098616191 hasConcept C2779561371 @default.
- W2098616191 hasConcept C2780091579 @default.
- W2098616191 hasConcept C2908929049 @default.
- W2098616191 hasConcept C71924100 @default.